Special report: recent developments in prostate cancer genetics and genetic testing
BlueCross BlueShield Association
Record ID 32010000219
English
Authors' objectives:
This Special Report is intended to be a horizon-scanning catalog of nucleic acid-based tests related to prostate cancer risk, detection, or prognosis that are currently available or are likely to be available in the near future. It does not address the question as to whether the TEC criteria are met.
Details
Project Status:
Completed
Year Published:
2008
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Antigens, Neoplasm
- DNA Methylation
- Genetic Predisposition to Disease
- Male
- Risk Assessment
- Serine Endopeptidases
- Genetic Testing
- Polymorphism, Single Nucleotide
- Prostatic Neoplasms
Contact
Organisation Name:
BlueCross BlueShield Association
Contact Address:
BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
tec@bcbsa.com
Contact Email:
tec@bcbsa.com
Copyright:
BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.